Brigit Biofarmaka Teknologi Tbk. vs Supra Boga Lestari Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume), while Supra Boga Lestari Tbk. trades at Rp520 (market cap 821.36B, 6.5K 24h volume). The key difference: Supra Boga Lestari Tbk. is far larger — about 5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (62.5K versus 6.5K). Which is the better fit depends on your goals.
| OBAT | RANC | |
|---|---|---|
Market Cap | 164.65B | 821.36B |
Volume | 62.5K | 6.5K |
Lot | 625 | 65 |
Turnover | 15.03M | 3.39M |
Average Price | 240.55 | 520.85 |
Value | 15.03M | 3.39M |
Indicative Equilibrium Price | 238 | 520 |
Indicative Equilibrium Volume | 100 | 10 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Supra Boga Lestari Tbk (the Company) was established in Indonesia based on Notarial Deed No. 34 of Suwarni Sukiman, S.H., dated May 28, 1997.
Read more on RANC →